Eli Lilly and Company: all 2,262 studies
Page 2 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)RecruitingNCT07241390Phase 3
- A Study of LY4584180 in Adult Participants With Previously Treated Blood CancersRecruitingNCT07226843Phase 1
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid RelapseRecruitingNCT07223840Phase 2
- Efficacy and Safety of Orforglipron in Participants With Peripheral Artery DiseaseRecruitingNCT07223593Phase 3
- A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)RecruitingNCT07222332Phase 3
- A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and AdultsRecruitingNCT07222137Phase 3
- A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use DisorderRecruitingNCT07219966Phase 3
- A Study of Brenipatide in Participants With Alcohol Use DisorderRecruitingNCT07219953Phase 3
- A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruitingNCT07219173Phase 2
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractRecruitingNCT07218380Phase 3
- A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecruitingNCT07218341Phase 4
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruitingNCT07213804Phase 3
- A Study of LY4337713 in Participants With FAP-Positive Solid TumorsRecruitingNCT07213791Phase 1
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightRecruitingNCT07202884Phase 3
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:RecruitingNCT07186101Phase 2
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)RecruitingNCT07174336Phase 3
- A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerRecruitingNCT07169851Phase 2
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)RecruitingNCT07165028Phase 3
- A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver ImpairmentRecruitingNCT07165002Phase 1
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)RecruitingNCT07157774Phase 3
- Epidemiology and Biomarker Study in Alzheimer's DiseaseRecruitingNCT07142954Phase 3
- A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive ComplaintRecruitingNCT07140744Not applicable
- A Study of LY4257496 in Participants With Cancer (OMNIRAY)RecruitingNCT07114601Phase 1
- A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )RecruitingNCT07101328Phase 1
- A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisRecruitingNCT07100119Phase 1
- A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaRecruitingNCT07096674Phase 2
- A Study of LY4088044 in Healthy ParticipantsRecruitingNCT07090785Phase 1
- A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of AgeRecruitingNCT07082829Phase 1
- A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy ParticipantsRecruitingNCT07046559Phase 1
- A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesRecruitingNCT06945406Phase 1
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruitingNCT06937099Phase 3
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRecruitingNCT06937086Phase 3
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruitingNCT06897475Phase 2
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerRecruitingNCT06890598Phase 3
- A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaRecruitingNCT06876662Phase 4
- A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibRecruitingNCT06876649Phase 4
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RecruitingNCT06857942Phase 4
- An Open-Label Pilot Study of VTX2735 in Recurrent PericarditisRecruitingNCT06836232Phase 2
- A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseaseRecruitingNCT06809400Phase 1
- A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaRecruitingNCT06752668Phase 2
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)RecruitingNCT06739122Phase 3
- A Study of Pirtobrutinib in Participants With Immune ThrombocytopeniaRecruitingNCT06721013Phase 1/2
- Long Term Follow-up Study of AAVAnc80-hOTOF Gene TherapyEnrolling by invitationNCT06696456
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related ComorbiditiesRecruitingNCT06672939Phase 3
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)RecruitingNCT06672549Phase 3
- A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)RecruitingNCT06657768Phase 1
- A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecruitingNCT06588478Phase 2
- A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's DiseaseRecruitingNCT06566170
- A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's DiseaseRecruitingNCT06565195Phase 1
- Anti-VEGF Gene Therapy Trial for Vestibular SchwannomaRecruitingNCT06517888Phase 1/2
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- Phase 1b Study of VERVE-201 in Patients With Refractory HyperlipidemiaRecruitingNCT06451770Phase 1
- A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)RecruitingNCT06439277Phase 3
- A Study of Sofe-M in Participants With Selected Advanced Solid TumorsRecruitingNCT06400472Phase 1
- A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)RecruitingNCT06343805Phase 1
- A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)RecruitingNCT06338995Phase 3
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseaseRecruitingNCT06297590Phase 1
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruitingNCT06226883Phase 2
- A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery DiseaseRecruitingNCT06164730Phase 1
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruitingNCT06143956Phase 2
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruitingNCT06119581Phase 3
- Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular DiseaseEnrolling by invitationNCT06112327
- A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerRecruitingNCT05999994Phase 2
- A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainRecruitingNCT05986292Phase 2
- Gene Therapy Trial for Otoferlin Gene-mediated Hearing LossRecruitingNCT05821959Phase 3
- First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsRecruitingNCT05768139Phase 1/2
- A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisEnrolling by invitationNCT05735483Phase 3
- A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia AreataRecruitingNCT05723198Phase 3
- An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant DepressionRecruitingNCT05660642Phase 2
- FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3RecruitingNCT05614739Phase 1
- Otoferlin Gene-mediated Hearing Loss Natural History StudyRecruitingNCT05572073
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's DiseaseRecruitingNCT05509777Phase 3
- A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)RecruitingNCT05254743Phase 3
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)RecruitingNCT04844606Phase 3
- A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic ArthritisRecruitingNCT03773965Phase 3
- Master Rollover Protocol for Continued Safety Assessment of Study DrugAvailableNCT02632994
- Zyprexa® Relprevv™ Patient Care ProgramEnrolling by invitationNCT01088386
- A Study of LY3549492 in Healthy Weight Adult ParticipantsTerminatedNCT07085468Phase 2Results posted
- A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 DiabetesTerminatedNCT07030868Phase 2Results posted
- Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in ObesityCompletedNCT06771115Phase 2Results posted
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy ParticipantsCompletedNCT06704763Phase 1Results posted
- A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT06602219Phase 2Results posted
- A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy ParticipantsCompletedNCT06475729Phase 1Results posted
- Lebrikizumab Pen Ease of Use in Participants With Atopic DermatitisCompletedNCT06444165Phase 3Results posted
- A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or OverweightCompletedNCT06440980Phase 1Results posted
- A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy ParticipantsCompletedNCT06370728Phase 1Results posted
- A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in IndiaCompletedNCT06370715Phase 4Results posted
- A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT06280716Phase 3Results posted
- A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy ParticipantsCompletedNCT06258174Phase 1Results posted
- A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese ParticipantsCompletedNCT06243198Phase 1Results posted
- A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or OverweightCompletedNCT06230523Phase 2Results posted
- A Study of LY3541860 in Adult Participants With Relapsing Multiple SclerosisTerminatedNCT06220669Phase 2Results posted
- A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy ParticipantsCompletedNCT06215521Phase 1Results posted
- A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy ParticipantsCompletedNCT06215430Phase 1Results posted
- A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy ParticipantsCompletedNCT06194214Phase 1Results posted
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminCompletedNCT06192108Phase 3Results posted
- Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy ParticipantsCompletedNCT06190691Phase 1Results posted
- Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy ParticipantsCompletedNCT06190678Phase 1Results posted
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese ParticipantsCompletedNCT06186622Phase 1Results posted
- A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult ParticipantsCompletedNCT06181006Phase 1Results posted